Philip Morgan

Corhythm, Inc. develops devices for the treatment of atrial fibrillation. The firm offers device that uses semiconductor technology to provide pacing and defibrillation and delivers targeted medications when an atrial fibrillation is detected. The company was founded by Mir Imran in 2007 and is headquartered in San Antonio, TX.

Fe3 Medical, Inc. develops a transdermal therapy for iron deficiency anemia. It offers a disposable transdermal patch that delivers the amount of iron needed directly through the skin, bypassing the GI tract and eliminating undesirable side effects. The company was founded by Mir A. Imran in 2008 and is headquartered in San Antonio, TX.

InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA.

ePlanet Capital Advisors US Inc (ePlanet Capital) is a venture capital firm founded in 1999 by Asad Jamal. The firm is headquartered in San Jose, California.

NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL.

Jenken Biosciences, Inc. operated as a pharmaceutical company. It specialized in the development and commercialization of small molecules as toll-like receptor 4 (TLR4) antagonists. The company was founded by Edwin Wu in 2003 and was headquartered in Durham, NC.

GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC